Recognizing the early signs and symptoms of Alzheimer's disease in long-term care

Alzheimer's Care Today

Volumn 11, Issue 3, 2010, Pages 196-205

  Grossberg, George T ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Delirium; Depression; Long term care

Indexed keywords

EID: 77958066058     PISSN: 19363001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Alzheimer's Association. 2009 Alzheimer's disease facts and figures. http://www.alz.org/national/documents/report-aMactsfigures.2009.pdf. Accessed September 16, 2009.
2. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998;88(9):1337-1342.
3. Feldman H, Woodward M. The staging and assessment of moderate to severe Alzheimer disease. Neurology. 2005;65:S10-S17.
4. Rimmer E,Wojciechowska M, Stave C, et al. Implications of the Facing Dementia Survey for the general population, patients and caregivers across Europe. Int J Clin Pract. 2005;59(suppl 146):17-24. (Pubitemid 40333121)
5. Winblad B, Brodaty H, Gauthier S, et al. Pharma-cotherapy of Alzheimer's disease: is there a need to redefine treatment success? Int J Geriatr Psychiatry. 2001;16(7):653-666.
6. Cummings JL. Alzheimer's disease. N Engl J Med. 2004;351(1):56-67.
7. Alzheimer's Association. 10 signs of Alzheimer's. http://www.alz.org/ alzheimers-disease-10-signs-of-alzheimers.asp. Accessed July 13, 2009.
8. American Society of Consultant Pharmacists. Overview of MDS. http://www.ascp.com/resources/index/mds.cfm. Accessed January 15, 2010.
9. Centers for Medicare & Medicaid Services. Minimum Data Set (MDS)-Version 2.0 for Nursing Home Resident Assessment and Care Screening. http://www.cms.hhs.gov/NursingHomeQualityInits/ downloads/MDS20MDSALLForms.pdf. Accessed January 15,2010.
10. Shin JH, Scherer Y. Advantages and disadvantages of using MDS data in nursing research. J Gerontol Nurs. 2009;35(1):7-17.
11. Hartmaier SL, Sloane PD, Guess HA, Koch GG, Mitchell CM, Phillips CD.Validation of the Minimum Data Set Cognitive Performance Scale: agreement with the Mini-Mental State Examination. J Gerontol A Biol Sci Med Sci. 1995;50(2):M128-M133.
12. Paquay L, De Lepeleire J, Schoenmakers B,Ylieff M, Fontaine O, Buntinx F. Comparison of the diagnostic accuracy of the Cognitive Performance Scale (Minimum Data Set) and the Mini-Mental State Exam for the detection of cognitive impairment in nursing home residents. Int J Geriatr Psychiatry. 2007;22(4):286-293.
13. Zimmerman S, Sloane PD,Williams CS, et al. Residential care/assisted living staff may detect undiagnosed dementia using the minimum data set cognition scale.J Am Geriatr Soc. 2007;55(9):1349-1355.
14. Centers for Medicare & Medicaid Services. MDS 3.0 for Nursing Homes and Swing Bed Providers. http://www.cms.hhs.gov/NursingHomeQualityInits/ 25-NHQIMDS30.asp. Accessed January 15, 2010.
15. Chodosh J, Edelen MO, Buchanan JL, et al. Nursing home assessment of cognitive impairment: development and testing of a brief instrument of mental status.J Am Geriatr Soc. 2008;56(11):2069-2075.
16. Duffy FF, Chung H,Trivedi M, Rae DS, Regier DA, Katzelnick DJ. Systematic use of patient-rated depression severity monitoring: is it helpful and feasible in clinical psychiatry? Psychiatr Serv. 2008;59(10): 1148-1154.
17. American Medical Director's Association Dementia Clinical Practice Guideline.Columbia, MD: American Medical Director's Association; 2009.
18. Barton C, Miller B,Yaffe K. Improved evaluation and management of cognitive impairment: results of a comprehensive intervention in long-term care. J Am Med Dir Assoc. 2006;7(2):84-89.
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition-Text Revision. Washington, DC: American Psychiatric Association Press; 2000.
20. Starkstein SE, Mizrahi R, Power BD. Depression in Alzheimer's disease: phenomenology, clinical correlates and treatment. Int Rev Psychiatry. 2008;20(4): 382-388.
21. Voyer P, Richard S, Doucet L, Danjou C, Carmichael PH. Detection of delirium by nurses among long-term care residents with dementia. BMC Nurs. 2008;7:4.
22. Merck Manual Online-Home Edition for Patients and Caregivers. Delirium and Dementia. http://www.merck.com/mmhe/sec06/ch083/ch083a.html. Accessed January 21, 2010.
23. Pae CU, Marks DM, Han C, Patkar AA, Masand P. Delirium: underrecognized and undertreated. Curr Treat Options Neurol. 2008;10(5):386-395.
24. Steis MR, Fick DM. Are nurses recognizing delirium? A systematic review. J Gerontol Nurs. 2008;34(9): 40-48.
25. Fong TG, Tulebaev SR, Inouye SK. Delirium in elderly adults: diagnosis, prevention and treatment. Nat Rev Neurol. 2009;5(4):210-220.
26. Singer C, Luxenberg J. Diagnosing dementia in long-term care facilities. J Am Med Dir Assoc. 2003;4(6) (suppl):S134-S140.
27. Fillit HM, Doody RS, Binaso K, et al. Recommendations for best practices in the treatment of Alzheimer's disease in managed care. Am J Geriatr Pharmacother. 2006;4(suppl A):S9-S24.
28. Aricept [package insert].Teaneck,NJ:Eisai Inc; 2006.
29. Exelon [package insert].East Hanover,NJ:Novartis; 2004.
30. Razadyne [package insert]. Titusville, NJ: Ortho-McNeill Neurologics, Inc; 2008.
31. Namenda [package insert]. St. Louis, MO: Forest Laboratories, Inc; 2007.
32. Smith DA. Treatment of Alzheimer's disease in the long-term-care setting. Am J Health Syst Pharm. 2009;66(10):899-907.
33. Bright-Long L. Alzheimer's treatment in nursing homes: room for improvement. J Am Med Dir Assoc. 2006;7(2):90-95.
34. Geldmacher DS, Frolich L, Doody RS, et al. Realistic expectations for treatment success in Alzheimer's disease.J Nutr Health Aging. 2006;10(5):417-429.
35. Wilkinson D, Schindler R, Schwam E, et al. Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate Alzheimer's disease.Dement Geriatr Cogn Disord. 2009;28(3): 244-251.
36. Brangman SA. Long-term cholinesterase inhibitor therapy for Alzheimer's disease: implications for long-term care. Am J Alzheimers Dis Other Demen. 2003;18(2):79-84.
37. Andersen CK,Wittrup-Jensen KU, Lolk A,Andersen K, Kragh-Sorensen P. Ability to perform activities of daily living is the main factor affecting quality of life in patients with dementia. Health Qual Life Outcomes. 2004;2(1):52.
38. Winblad B, Kilander L, Eriksson S, et al. Donepezil in patients with severe Alzheimer's disease: doubleblind, parallel-group, placebo-controlled study. Lancet. 2006;367(9516):1057-1065.